Skip to content
DataLookout
Menu

NMIBS_MedDietNCT07901972

Nutritional Management of the Irritable Bowel Syndrome(IBS): The Role of the Mediterranean Diet (MD)

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Change in symptom severity from baseline to post-intervention, assessed using a validated disease-specific questionnaire.
Timeframe: Baseline, 6 Weeks and 6 months

Secondary (4)

Assessment of IBS-related quality of life using a disease-specific questionnaire before and after the intervention, with comparisons between the study groups.
Bristol Stool Form Scale (BSFS), Type 1-7
Assessment of anxiety and depressive symptoms before and after the intervention.
Mediterranean Diet Adherence Score

Arms and interventions

Mediterranean Standard DietActive comparator

All participants in this group will be instructed to follow Mediterranean diet recommendations, based on the Greek National Dietary Guidelines, for the management of Irritable Bowel Syndrome for a period of 6 weeks.

Mediterranean Modified Low FODMAP DietExperimental

All participants in this group will initially follow the Mediterranean Modified Low FODMAP Diet during Phase 1 (the elimination phase) for 6 weeks. During Phase 2 (the reintroduction phase), patients will gradually reintroduce foods high in FODMAPs over a period of 6-8 weeks and assess their individual tolerance. During Phase 3 (the maintenance phase), following the reintroduction of high-FODMAP foods, patients will follow an individualized diet based on their personal tolerance, combining high- and low-FODMAP foods.

Other: Mediterranean Standard Diet, Mediterranean Modified Low FODMAP Diet